These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26539578)

  • 1. [Alcohol use disorders in elderly people calls for treatment].
    Wieben ES; Nielsen B; Nielsen AS; Andersen K
    Ugeskr Laeger; 2015 Apr; 177(18):837-40. PubMed ID: 26539578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alcohol use disorders in elderly people calls for treatment].
    Wieben ES; Nielsen B; Nielsen AS; Andersen K
    Ugeskr Laeger; 2014 Sep; 176(37):. PubMed ID: 25294031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol use and anxiety: diagnostic and management issues.
    Brady KT; Tolliver BK; Verduin ML
    Am J Psychiatry; 2007 Feb; 164(2):217-21; quiz 372. PubMed ID: 17267782
    [No Abstract]   [Full Text] [Related]  

  • 4. Adoption of naltrexone to treat alcohol dependence.
    Fuller BE; Rieckmann T; McCarty D; Smith KW; Levine H
    J Subst Abuse Treat; 2005 Apr; 28(3):273-80. PubMed ID: 15857728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating depression along with alcohol dependence.
    Harv Ment Health Lett; 2010 Jul; 27(1):7. PubMed ID: 20812413
    [No Abstract]   [Full Text] [Related]  

  • 6. Naltrexone in the treatment of binge eating disorder in a patient with severe alcohol use disorder: a case report.
    Leroy A; Carton L; Gomajee H; Bordet R; Cottencin O
    Am J Drug Alcohol Abuse; 2017 Sep; 43(5):618-620. PubMed ID: 28301250
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-acting injectable depot naltrexone use in the Veterans' Health Administration: a national study.
    Marienfeld C; Iheanacho T; Issa M; Rosenheck RA
    Addict Behav; 2014 Feb; 39(2):434-8. PubMed ID: 23790742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Evaluation of Motivational Interviewing Training for Mandated Implementation of Alcohol Screening and Brief Intervention in Trauma Centers.
    Darnell D; Dunn C; Atkins D; Ingraham L; Zatzick D
    J Subst Abuse Treat; 2016 Jan; 60():36-44. PubMed ID: 26117081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teaching family medicine residents brief interventions for alcohol misuse.
    Rule JC; Samuel P
    Int J Psychiatry Med; 2015; 50(1):81-91. PubMed ID: 26130770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone in alcohol dependence.
    Hartmann PM
    Am Fam Physician; 1997 Apr; 55(5):1877-9, 1883-4. PubMed ID: 9105212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.
    Foa EB; Yusko DA; McLean CP; Suvak MK; Bux DA; Oslin D; O'Brien CP; Imms P; Riggs DS; Volpicelli J
    JAMA; 2013 Aug; 310(5):488-95. PubMed ID: 23925619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AUDIT-C scores as a scaled marker of mean daily drinking, alcohol use disorder severity, and probability of alcohol dependence in a U.S. general population sample of drinkers.
    Rubinsky AD; Dawson DA; Williams EC; Kivlahan DR; Bradley KA
    Alcohol Clin Exp Res; 2013 Aug; 37(8):1380-90. PubMed ID: 23906469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial.
    Martinotti G; Di Nicola M; Tedeschi D; Andreoli S; Reina D; Pomponi M; Mazza M; Romanelli R; Moroni N; De Filippis R; Di Giannantonio M; Pozzi G; Bria P; Janiri L
    J Psychopharmacol; 2010 Sep; 24(9):1367-74. PubMed ID: 19346279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicaid coverage of medications to treat alcohol and opioid dependence.
    Mark TL; Lubran R; McCance-Katz EF; Chalk M; Richardson J
    J Subst Abuse Treat; 2015 Aug; 55():1-5. PubMed ID: 25921475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol abuse and alcoholism: an overview.
    Volpicelli JR
    J Clin Psychiatry; 2001; 62 Suppl 20():4-10. PubMed ID: 11584874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
    Buri C; Moggi F; Giovanoli A; Strik W
    Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early detection, negotiation and treatment of alcohol use disorders in primary care].
    Reimer J; Cimander KF; Reimer C
    Dtsch Med Wochenschr; 2014 May; 139(18):943-52; quiz 953-6. PubMed ID: 24760716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alcohol consumption in opioid-dependence patients in treatment with naltrexone].
    Ochoa Mangado E; Arias Horcajadas F
    Actas Esp Psiquiatr; 2000; 28(4):239-49. PubMed ID: 11116795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nature and Treatment of Comorbid Alcohol Problems and Post Traumatic Stress Disorder Among American Military Personnel and Veterans.
    Allen JP; Crawford EF; Kudler H
    Alcohol Res; 2016; 38(1):133-40. PubMed ID: 27159820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.